INCYTE GENOMICS INC (INCY)

Overview Price 17.22 Price Change Today -$0.20 (-1.15%) P&P rating Zacks Rank 3 - HOLD Open Price $17.39 Previous Close $17.42 Daily Range $17.04 - $17.52 52-Week Range $11.76 - $21.15 Volume 1,294,988 Incyte Corp is a drug discovery company that is using its expertise in genomics, medicinal chemistry and molecular, cellular and in vivo biology to discover and develop novel therapeutics. The company has three fully-staffed drug discovery programs underway focused primarily on the identification of new small molecule drugs for cancer and inflammation. Incyte also has strategic alliances with Lexicon Genetics and Medarex focused on the discovery and development of protein therapeutics or antibodies to treat inflammatory diseases and cancer. Other Resources for INCY Detailed Quote Earnings Estimates Company Report Interactive Chart Commentary Zacks Blog: Incyte Drug Cleared in the US November 17, 2011 Zacks Blog: Loss Widens at Incyte November 2, 2011 Zacks Blog: Neutral View on Incyte August 30, 2011 Zacks Blog: Incyte Does Not Excite August 1, 2011 Zacks Blog: Novartis Beats Soundly July 19, 2011 Incyte Corp is a drug discovery company that is using its expertise in genomics, medicinal chemistry and molecular, cellular and in vivo biology to discover and develop novel therapeutics. The company has three fully-staffed drug discovery programs underway focused primarily on the identification of new small molecule drugs for cancer and inflammation. Incyte also has strategic alliances with Lexicon Genetics and Medarex focused on the discovery and development of protein therapeutics or antibodies to treat inflammatory diseases and cancer.   Brokerage Analyst Recommendations 16 Brokerage Firms Covering INCY   Strong Buy 13 Buy 1 Hold 2 Sell 0 Strong Sell 0 Average Broker Recommendation (ABR): 1.28   INCY Ratings: BUY  SELL  HOLD INCY Consensus Forecasts

Rate this Stock! You haven't rated this stock yet! Ticker Call Buy Sell Analysis Time Frame Week or Less Week to a Month One to Three Months Three to Six Months Six Months to a Year One to Three Years Three Plus Years What The Community Thinks Total Players 26 Buy 0 Sell   Top Buy Analysis BUY: INCY Company: INCYTE CORPORATION Points: 26.31 Start Price: $12.36 Start Date: 11/29/2011 2:23 PM InvestmentMAGE P&P Score: 99.93 Recs: Incyte announced the approval of Jakafi (ruxolitinib) MAGE (BMC) (r) Comments: 0 | Comment More Recent Analysis Top Sell Analysis No Sell Analysis. Be the First. More Recent Analysis

Blog Posts

User	User Score	Date	Title	Comments	Last Comment
rjm77me	99.92	12/02/11	Insider Buys/ Sells	0
rjm77me	99.92	11/11/11	STOCKS MAKING 52 WEEK HIGH / LOW	3	11/11/11
Zacks_Analysts	0.00	11/17/11	Incyte Drug Cleared in the US - Analyst Blog	0
Zacks_Analysts	0.00	11/02/11	Loss Widens at Incyte - Analyst Blog	0
Zacks_Analysts	0.00	08/30/11	Neutral View on Incyte - Analyst Blog	0
Zacks_Analysts	0.00	07/19/11	Novartis Beats Soundly - Analyst Blog	0
Zacks_Analysts	0.00	07/05/11	Eli Lilly Provides R&D Update - Analyst Blog	0
Zacks_Analysts	0.00	06/15/11	Risk-Reward Balanced at Incyte - Analyst Blog	0
Zacks_Analysts	0.00	06/13/11	Incyte Gives Lead Candidate Data - Analyst Blog	0
Zacks_Analysts	0.00	06/08/11	Novartis Presents INC424 Data - Analyst Blog	1	06/08/11

Pages: [ 1 ]  2   3   4  >>

Commentary

BUY: INCYTE CORPORATION (INCY) Start Price: $18.29 Points: -8.61 Created: 01/24/2012 Pretty stable bio stock. I think the upgrade will help it get over the $20 threshold. Comments: 0 | Comment Hot_Commodity Recs:

BUY: INCYTE CORPORATION (INCY) Start Price: $12.36 Points: +26.31 Created: 11/29/2011 Incyte announced the approval of Jakafi (ruxolitinib) MAGE (BMC) (r) Comments: 0 | Comment InvestmentMAGE Recs:

BUY: INCYTE CORPORATION (INCY) Start Price: $18.16 Points: -9.98 Created: 06/09/2011 Broke downtrend Comments: 0 | Comment wallstreeter Recs:

BUY: INCYTE CORPORATION (INCY) Start Price: $12.08 Points: +29.33 Created: 11/20/2011 kljlj Comments: 0 | Comment Yade Recs:

BUY: INCYTE CORPORATION (INCY) Start Price: $5.26 Points: +235.49 Created: 01/01/2008 Comments: 0 | Comment Skuros Recs:

BUY: INCYTE CORPORATION (INCY) Start Price: $4.19 Points: +319.14 Created: 01/01/2008 Comments: 0 | Comment abr Recs:

BUY: INCYTE CORPORATION (INCY) Start Price: $5.83 Points: +203.46 Created: 01/01/2008 Comments: 0 | Comment puddine Recs:

BUY: INCYTE CORPORATION (INCY) Start Price: $5.32 Points: +231.79 Created: 01/01/2008 Comments: 0 | Comment jimcarroll Recs:

BUY: INCYTE CORPORATION (INCY) Start Price: $3.57 Points: +390.55 Created: 01/01/2008 Comments: 0 | Comment pepelulu Recs:

BUY: INCYTE CORPORATION (INCY) Start Price: $9.34 Points: +92.40 Created: 01/01/2008 Comments: 0 | Comment cecildslayton Recs:

Pages: [ 1 ]  2   3  >>

Picks

Username	P&P Score	Call	Time Frame	Start Date	Start Price	Today (change)	Stock Gain	S&P Gain	Points	Analysis
Hot_Commodity	99.66	BUY	Three to Six Months	01/24/2012	$18.29	$17.23 (-0.69%)	-5.80%	+2.82%	-8.61	view close
InvestmentMAGE	99.93	BUY	Six Months to a Year	11/29/2011	$12.36	$17.23 (-0.69%)	+39.40%	+13.09%	+26.31	view close
Yade	99.88	BUY	One to Three Years	11/20/2011	$12.08	$17.23 (-0.69%)	+42.63%	+13.30%	+29.33	view close
wallstreeter	0.23	BUY	Six Months to a Year	06/09/2011	$18.16	$17.23 (-0.69%)	-5.12%	+4.86%	-9.98	view close
Skuros	59.97	BUY	Six Months to a Year	01/01/2008	$5.26	$17.23 (-0.69%)	+227.57%	-7.92%	+235.49
abr	43.28	BUY	Six Months to a Year	01/01/2008	$4.19	$17.23 (-0.69%)	+311.22%	-7.92%	+319.14
puddine	83.02	BUY	Six Months to a Year	01/01/2008	$5.83	$17.23 (-0.69%)	+195.54%	-7.92%	+203.46
jimcarroll	72.43	BUY	Six Months to a Year	01/01/2008	$5.32	$17.23 (-0.69%)	+223.87%	-7.92%	+231.79
pepelulu	72.43	BUY	Six Months to a Year	01/01/2008	$3.57	$17.23 (-0.69%)	+382.63%	-7.92%	+390.55
cecildslayton	62.01	BUY	Six Months to a Year	01/01/2008	$9.34	$17.23 (-0.69%)	+84.48%	-7.92%	+92.40

Pages: [ 1 ]  2   3  >>